Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 859-869-7 | CAS number: 201419-80-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model, but not (completely) falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- QSAR
- Principles of method if other than guideline:
- QSAR
- GLP compliance:
- no
- Key result
- Species / strain:
- not specified
- Remarks:
- QSAR
- Metabolic activation:
- not specified
- Genotoxicity:
- positive
- Remarks:
- QSAR
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- QSAR
- Vehicle controls validity:
- not specified
- Remarks:
- QSAr
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- QSAR
- Conclusions:
- Computational tool: Leadscope
Genotoxicity potential as chromosome aberration in vitro for the target 2,4,8,10-Tetraoxa-3,9-
dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide was estimated by (Q)SAR methodology employing a battery of
models, including ACD/Percepta, ChemTunes/ToxGPS and Leadscope. Following a detailed assessment of
the generated (Q)SAR predictions, the most reliable prediction was provided by Leadscope.
Leadscope model for in vitro chromosome aberration test using Chinese hamster lung cells (Genotox
Suite/Clastogenicity in vitro/Chromosome aberration CHL) estimates the probability that a compound will
result positive in the experimental assay. Leadscope results include a genotoxicity prediction (positive,
negative or not in domain), a positive prediction probability and two parameters which assess model
applicability domain, i.e. Model Features Count and 30% Similarity Training Neighbours Count. Leadscope
prediction for the target 2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide is positive. - Executive summary:
Genotoxicity - chromosome aberrationin vitro(CHL) prediction is positive.
It is classifed as Mutagen 1. H340
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model, but not (completely) falling into its applicability domain, with adequate and reliable documentation / justification
- Principles of method if other than guideline:
- QSAR
- GLP compliance:
- no
- Key result
- Sex:
- not specified
- Genotoxicity:
- positive
- Toxicity:
- not specified
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Remarks on result:
- other: QSAR
- Conclusions:
- Computational tool: ACD/Percepta
Genotoxicity potential as micronucleus in vivo on rodent for the target 2,4,8,10-Tetraoxa-3,9-
dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide was estimated by (Q)SAR methodology employing a battery of
models, including ACD/Percepta, ChemTunes/ToxGPS and Leadscope. Following a detailed assessment of
the generated (Q)SAR predictions, the most reliable prediction was provided by ACD/Percepta.
ACD/Percepta model for micronucleus in vivo composite (rodent) estimates probability (“p-value”) that a
compound will result positive in the micronucleus test on rodents. The reliability of prediction is assessed in
terms of reliability index (RI), which ranges from 0 to 1 and takes into account the similarity of the target
with the training set compounds and the consistency of experimental values for similar compounds. A
“positive” or “negative” call is provided if the compound can be reliably classified on the basis of p and RI
values (“Undefined” otherwise). ACD/Percepta genotoxicity prediction as micronucleus in vivo (composite)
for the target compound 2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide is positive. - Executive summary:
Genotoxicity - micronucleusin vivoprediction is positive.
It is classifed as Mutagen 1. H340
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
Justification for classification or non-classification
H340 mutagen
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
